UL Stock Analysis: Unilever | NYSE

Household & Personal Products | NYSE, USA | Market Cap: 143.866m USD | 12M Return: -0.2% | US9047678035 | Charts, Fundamentals & Technical Analysis

Hair Care, Deodorants, Detergents, Foods
Total Rating 47
Safety 66
Buy Signal 0.00
Personal Care Products
Sub-Industry Rotation: +2.7
Market Cap: 144B
Avg Turnover: 247M
Risk 3d forecast
Volatility19.8%
VaR 5th Pctl3.16%
VaR vs Median-2.91%
Reward TTM
Sharpe Ratio-0.04
Rel. Str. IBD58.3
Rel. Str. Peer Group15.6 pctl
Character TTM
Beta-0.281
Beta Downside-0.447
Hurst Exponent0.470
Choppyness58.5%
Drawdowns 3y
Max DD25.09%
CAGR/Max DD0.39
CAGR/Mean DD1.28

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan -0.1% 0
Feb -0.3% 4
Mar +1.6% 14
Apr +3.1% 73
May +0.7% 14
Jun -0.5% 14
Jul +2.4% 28
Aug -0.6% 14
Sep -2.8% 28
Oct -1.3% 0
Nov +0.0% 0
Dec -2.2% 21

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: UL Unilever

Unilever PLC is a multinational fast-moving consumer goods (FMCG) company headquartered in London, operating across Asia Pacific, Africa, the Americas, and Europe through four segments: Beauty & Wellbeing, Personal Care, Home Care, and Foods. Its portfolio covers everyday essentials such as shampoo, skin care, soap, deodorants, oral care, laundry and cleaning products, soups, seasonings, and condiments, marketed under widely recognized brands including Dove, Hellmanns, Knorr, Vaseline, TRESemmé, and Sunsilk. Founded in 1860, the company trades on the NYSE as an American Depositary Receipt (ADR) under the ticker UL. As a Consumer Staples issuer classified in the Personal Care Products sub-industry, Unilevers business model is built on high-volume, recurring demand for household and personal care items, which typically generates stable cash flows across economic cycles.

Headlines to Watch Out For
  • Ice cream spin-off creates focused faster-growing staples entity
  • Beauty & Wellbeing premium brands drive margin expansion
  • Emerging markets currency headwinds pressure reported revenue growth
Piotroski VR-10 (Strict) 5.5
Net Income: 9.27b TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.53 > 1.0
NWC/Revenue: -16.31% < 20% (prev -9.89%; Δ -6.42% < -1%)
CFO/TA 0.11 > 3% & CFO 8.36b > Net Income 9.27b
Net Debt (27.6b) to EBITDA (10.6b): 2.59 < 3
Current Ratio: 0.74 > 1.5 & < 3
Outstanding Shares: last quarter (2.18b) vs 12m ago -13.05% < -2%
Gross Margin: 41.75% > 18% (prev 44.14%; Δ -2.38% > 0.5%)
Asset Turnover: 60.16% > 50% (prev 78.65%; Δ -18.49% > 0%)
Interest Coverage Ratio: 9.13 > 6 (EBIT TTM 9.42b / Interest Expense TTM 1.03b)
Altman Z'' 2.42
A: -0.10 (Total Current Assets 21.4b - Total Current Liabilities 28.9b) / Total Assets 76.9b
B: 0.60 (Retained Earnings 45.9b / Total Assets 76.9b)
C: 0.12 (EBIT TTM 9.42b / Avg Total Assets 76.5b)
D: 0.28 (Book Value of Equity 16.2b / Total Liabilities 58.6b)
Altman-Z'' = 2.42 = A
Beneish M -2.55
DSRI: 1.72 (Receivables 10.2b/7.69b, Revenue 46.0b/59.8b)
GMI: 1.06 (GM 44.14% / 41.75%)
AQI: 0.99 (AQ_t 0.60 / AQ_t-1 0.60)
SGI: 0.77 (Revenue 46.0b / 59.8b)
TATA: 0.01 (NI 9.27b - CFO 8.36b) / TA 76.9b)
Beneish M = -2.55 (Cap -4..+1) = A
What is the price of UL shares?

As of November 19, 2026, the stock is trading at USD 64.53 with a total of 3,021,531 shares traded. Over the past week, the price has changed by -1.12%, over one month by -0.16%, over three months by +4.86% and over the past year by -0.23%.

Current recommended Stop Loss: 62.60 (which is 3% or 1.5 ATR below the current price).

Is UL a buy, sell or hold?

Unilever has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy UL.

  • StrongBuy: 3
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the UL price?
Analysts Target Price 71.8 11.3%
Unilever (UL) - Fundamental Data Overview as of 18 November 2026
Market Cap USD = 144b (144b USD * 1.0 USD.USD)
Market Cap EUR = 131b (144b USD * 0.91149997711182 USD.EUR)
P/E Trailing = 13.3888
P/E Forward = 17.6367
P/S = 2.8421
P/B = 7.9355
P/EG = 7.0519
Revenue TTM = 46.0b EUR
EBIT TTM = 9.42b EUR
EBITDA TTM = 10.6b EUR
Long Term Debt = 24.1b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 8.14b EUR (from shortTermDebt, last quarter)
Debt = 33.4b EUR (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 27.6b EUR (calculated: Debt 33.4b - CCE 5.87b)
Enterprise Value = 159b EUR (131b + Debt 33.4b - CCE 5.87b)
Interest Coverage Ratio = 9.13 (Ebit TTM 9.42b / Interest Expense TTM 1.03b)
EV/FCF = 22.33x (Enterprise Value 159b / FCF TTM 7.11b)
FCF Yield = 4.48% (FCF TTM 7.11b / Enterprise Value 159b)
FCF Margin = 15.45% (FCF TTM 7.11b / Revenue TTM 46.0b)
Net Margin = 20.16% (Net Income TTM 9.27b / Revenue TTM 46.0b)
Gross Margin = 41.75% ((Revenue TTM 46.0b - Cost of Revenue TTM 26.8b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 2.06 (Enterprise Value 159b / Total Assets 76.9b)
Interest Expense / Debt = 3.09% (Interest Expense 1.03b / Debt 33.4b)
Taxrate = 31.30% (2.59b / 8.26b)
NOPAT = 6.47b (EBIT 9.42b * (1 - 31.30%))
Current Ratio = 0.74 (Total Current Assets 21.4b / Total Current Liabilities 28.9b)
Debt / Equity = 2.06 (Debt 33.4b / totalStockholderEquity, last quarter 16.2b)
Debt / EBITDA = 2.59 (Net Debt 27.6b / EBITDA 10.6b)
Debt / FCF = 3.88 (Net Debt 27.6b / FCF TTM 7.11b)
Total Stockholder Equity = 17.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.13% (Net Income 9.27b / Total Assets 76.9b)
RoE = 53.36% (Net Income TTM 9.27b / Total Stockholder Equity 17.4b)
RoCE = 22.71% (EBIT 9.42b / Capital Employed (Equity 17.4b + L.T.Debt 24.1b))
RoIC = 12.00% (NOPAT 6.47b / Invested Capital 53.9b)
WACC = 4.18% (E(131b)/V(165b) * Re(4.71%) + D(33.4b)/V(165b) * Rd(3.09%) * (1-Tc(0.31)))
Discount Rate = 4.71% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -83.27 | Cagr: -7.34%
[DCF] Terminal Value 76.36% ; FCFF base≈6.91b ; Y1≈7.36b ; Y5≈8.78b
[DCF] Fair Price = 49.84 (EV 135b - Net Debt 27.6b = Equity 107b / Shares 2.15b; r=8.35% [WACC [floored]]; 5y FCF grow 7.35% → 2.50% )
EPS Correlation: -19.39 | EPS CAGR: -5.38% | SUE: N/A | # QB: 0
Revenue Correlation: -10.83 | Revenue CAGR: -1.69% | SUE: 0.86 | # QB: 1
EPS current Quarter (2026-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2025-12-31): EPS=2.94 | Chg30d=+2.36% | Revisions=+25% | GrowthEPS=-12.3% | GrowthRev=-16.8%
EPS next Year (2026-12-31): EPS=3.21 | Chg30d=+0.30% | Revisions=+50% | GrowthEPS=+4.3% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: +57% (up=4, down=0)